// App-Quantinova.ai

: Multimodal Preventive Trial for Alzheimer’s Disease (MIND-ADMINI): Pilot trial progress and results

Researchers

Presenter

  • Miia Kivipelto

Principal Investigators

  • Shireen Sindi

  • Charlotta Thunborg

  • Anna Rosenberg

  • Nicola Coley

  • Sandrine Andrieu

  • Laus M. Broersen

  • Tobias Hartmann

  • Alina Solomon

  • Hilkka Soininen

Medical Centers

  • Karolinska Institutet,

  • Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London

  • INSERM, University of Toulouse

  • Danone Nutricia Research, Specialized Nutrition

  • University of the Saarland

  • Medical Unit Aging, Karolinska University Hospital

  • Imperial College, London, UK

  • University of Eastern Finland

  • Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet

  • Institute of Clinical Medicine/Neurology, University of Eastern Finland

  • Department of Neurology, Institute of Clinical Medicine and Institute of Public Health and Clinical Nutrition, University of Eastern Finland

Locations

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Controlled

  • Parallel Group

Phase

  • NA

Study Id's

  • NCT03249688

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved